A Multicenter Survey on Eligibility for a Randomized Phase III Trial of Adjuvant Chemotherapy for Resected Biliary Tract Cancer (JCOG1202, ASCOT).
Shin KobayashiMasafumi IkedaKohei NakachiMakoto UenoTakuji OkusakaAkiko TodakaSohei SatoiAkira TomokuniMasaru KonishiJunji FurusePublished in: Annals of surgical oncology (2023)
Patients undergoing surgery for BTC are a heterogeneous cohort comprising patients with earlier pathologic stage, advanced age, and prolonged postoperative complications. These factors should be considered during the design of future clinical trials of perioperative treatments for resectable BTC.
Keyphrases
- phase iii
- clinical trial
- patients undergoing
- double blind
- open label
- phase ii
- locally advanced
- minimally invasive
- papillary thyroid
- cross sectional
- placebo controlled
- coronary artery bypass
- neoadjuvant chemotherapy
- lymph node
- squamous cell
- cardiac surgery
- current status
- surgical site infection
- study protocol
- prognostic factors
- rectal cancer
- childhood cancer
- young adults
- acute coronary syndrome
- radiation therapy
- acute kidney injury
- percutaneous coronary intervention